Abstract: The present invention provides an antipsychotic drug comprising fasudil or a pharmaceutically acceptable salt thereof as an active agent for the treatment of schizophrenia, including schizophrenia caused by dysfunction of ARHGAP10.

Abstract: A wireless terminal cover is attached to a plate-like wireless terminal. The wireless terminal cover includes a bottom part that is in contact with the backside of the attached wireless terminal while covering the backside and is made of a dielectric having a relative dielectric constant of 1 to 10, wall parts that are in contact with the sides of the attached wireless terminal while surrounding the sides and are made of the dielectric, and a plurality of conductive elements placed in line on at least one of the bottom part and the wall part. The conductive elements are formed such that the length of the longest one of lines, each of which connects any two points on the conductive elements, is 0.1 to 0.4 times the effective wavelength of radio waves in the dielectric, the radio waves being used for radio communications by the wireless terminal.

Abstract: A wireless terminal cover is attached to a plate-like wireless terminal. The wireless terminal cover includes a bottom part that is in contact with the backside of the attached wireless terminal while covering the backside and is made of a dielectric having a relative dielectric constant of 1 to 10, wall parts that are in contact with the sides of the attached wireless terminal while surrounding the sides and are made of the dielectric, and a plurality of conductive elements placed in line on at least one of the bottom part and the wall part. The conductive elements are formed such that the length of the longest one of lines, each of which connects any two points on the conductive elements, is 0.1 to 0.4 times the effective wavelength of radio waves in the dielectric, the radio waves being used for radio communications by the wireless terminal.

Abstract: An object of the present invention is to provide a novel therapeutic agent for a mental disorder with abnormal neurodevelopment as a pathological condition. The present invention provides an antipsychotic drug containing a Rho kinase inhibitor as an active ingredient. The antipsychotic drug can be used, for example, in the treatment of schizophrenia, autism spectrum disorder, bipolar disorder, or depression.

Abstract: An object of the present invention is to provide a novel therapeutic agent for a mental disorder with abnormal neurodevelopment as a pathological condition. The present invention provides an antipsychotic drug containing a Rho kinase inhibitor as an active ingredient. The antipsychotic drug can be used, for example, in the treatment of schizophrenia, autism spectrum disorder, bipolar disorder, or depression.

Abstract: An object of the present invention is to provide a method for preparing dopamine neurons efficiently in a short period of time. The dopamine neuron is prepared by step of culturing pluripotent stem cells in the presence of a TGF-? family inhibitor, a GSK3? inhibitor, and a BMP inhibitor; step of suspension-culturing the cells obtained in step in the presence of a TGF-? family inhibitor, a GSK3? inhibitor, FGF8, and a hedgehog signal agonist and under normal oxygen partial pressure to form a neurosphere; and step of collecting the neurosphere to induce differentiation of the cells into dopamine neurons.

Abstract: An object of the present invention is to provide a novel evaluation system that is particularly useful in researches on the onset mechanism and pathologic conditions of a central nervous system disease, development of a therapeutic method, or the like. The efficacy of a test substance is evaluated using a movement pattern defined by variations in movement of individual cells constituting a cell population as an index.

Abstract: The object is to provide a combination of biomarkers which allow highly accurate discrimination of schizophrenia, and a utilization thereof. A combination of schizophrenia marker set including a combination of two or more protein molecules selected from the group consisting of trifunctional purine biosynthetic protein adenosine-3, uroporphyrinogen decarboxylase, interferon-induced GTP-binding protein Mx1, glutaredoxin-3, microtubule-associated protein RP/EB family member 1, tubulin folding cofactor B, immunoglobulin mu chain C region, and heat shock 70 kDa protein 4L is provided. In addition, a method for examining schizophrenia using the level of the marker set in a specimen as an index is provided.

Abstract: A battery housing frame includes a first side wall and a second side wall that hold a battery pack from both sides of the battery pack. The second side wall is elastic, and presses the battery pack towards the first side wall by contact pressure between one side of the battery pack housed in the battery housing.